- Arsanis Appoints David Mantus as Executive Vice President, Regulatory Affairs
- BOSTON and VIENNA, Nov. 4, 2015 /PRNewswire/ -- Arsanis, Inc., a development-stage biopharmaceutical company focused on monoclonal antibody therapeutics for severe infectious diseases, today announced that David Mantus, Ph.
- Arsanis Appoints Michael P. Gray as Chief Financial Officer and Chief Business
- Mr. Gray joins an experienced management team with a track record of success in infectious diseases, including: Eszter Nagy, MD, PhD, Arsanis co-founder and chief scientific officer; René Russo, PharmD, BCPS, chief development officer; David Mantus, ...
Mantus is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Mantus books and related discussion.